Randomized phase II study of lonaprisan as second-line...

Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer

Jonat, W., Bachelot, T., Ruhstaller, T., Kuss, I., Reimann, U., Robertson, J. F. R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt216
Date:
October, 2013
File:
PDF, 102 KB
english, 2013
Conversion to is in progress
Conversion to is failed